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Self-Expanding Stents for
Primary Percutaneous
Coronary Intervention During
Acute Myocardial Infarction
Did We Find the Right Indication . . . at Last!*
William Wijns, MD, Stylianos A. Pyxaras, MD
Aalst, Belgium
Most young colleagues may not be aware of the fact that
coronary stenting started back in Europe during the late
1980s with the delivery of self-expanding nitinol devices (1).
The coronary Wallstent (Boston Scientific, Natick, Massa-
chusetts) was indeed the first stent used in the coronary
circulation, be it in grafted saphenous veins or in native
coronary vessels of sufficient diameter (2). It is beyond the scope of
this editorial to review the history and all the controversies
of another age—details can be found in the relevant
chapters of the PCR-EAPCI Textbook of Interventional
Cardiovascular Medicine (3). We will summarize what we
have learned and what applies today in relation to the paper
by van Geuns et al. (4).
See page 1209
The rationale for preferring the use of self-expanding to
balloon-expandable stents remains the same. Adequate
sizing and stent selection that would allow proper expansion
still is problematic today. Failure to achieve proper expan-
sion results in the permanent implant of an incompletely
deployed, fixed metallic cage inside a dynamic vessel, with
increased risk of stent thrombosis and restenosis. The gentle
(as opposed to forceful) mechanics of stent expansion have
always seemed desirable, aiming at reducing plaque fracture,
edge dissections, and distal embolization of thrombus or
plaque debris. Even though the original Wallstent and
followers, such as the Radius device (Boston Scientific),
shared these desirable features, balloon expansion has
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were bulkier; some design characteristics were suboptimal;
and they are somewhat more delicate to deliver adequately.
Above all, it became obvious that restenosis rates were
unacceptable, as illustrated in the systematic study by Foley
et al. (5), who reported angiographic restenosis rates at 9
months ranging between 25.9% and 67.5% with increasing
stent length. Similar to the situation with balloon-
expandable stents, initial attempts at eliminating restenosis
used beta-radiation–based vascular brachytherapy (6),
which was soon followed by drug elution (7), but let us leave
this aspect on the side for the moment.
The STENTYS Device and Its Application to
Primary PCI for St-Segment Elevation
Myocardial Infarction
It is interesting to note that this new self-expanding device
was initially designed to tackle bifurcation lesions and in fact
can be used perfectly to treat such vessels and lesion subsets.
By design, struts can be disconnected easily by balloon
inflation toward a side branch (8), allowing either provi-
sional stenting with final kissing balloon inflation or double
stent implantation techniques to be performed readily. The
idea of applying the device to primary percutaneous coro-
nary intervention (PCI) procedures was first tested in the
APPOSITION I (Assessment of the Safety and Perfor-
mance of the STENTYS self-expanding Coronary Stent in
Acute Myocardial Infarction) trial (9), which demonstrated
the safety of the approach, and was soon followed with the
currently reported randomized trial (4). The specifics of
primary PCI seem ideally suitable for application of self-
expanding stents. This became obvious with the advent of
intracoronary imaging techniques, such as intravascular
ultrasound, and even more so using optical coherence
tomography (OCT). Indeed, stent apposition to the wall
and its components can now be assessed with exquisite
levels of detail and accuracy, at the individual strut level
while accounting for strut thickness. Presence of vasocon-
striction and a thrombotic milieu are risk factors for malap-
position of stent struts initially, as well as later. Initially
well-apposed stents struts were shown to become poorly
apposed after resolution of thrombus that covered the vessel
wall at the time of implantation.
Another brilliant component of the study rationale
pertains to the clinical situation, namely the constant
desire to minimize myocardial damage during evolving
infarction. This can be achieved primarily by reducing all
delays to reperfusion, but in those patients who did reach
the invasive laboratory in a timely fashion, prevention of
reperfusion-associated injury becomes of paramount im-
portance. Among the causes of reperfusion injury and no
reflow, distal embolization of disrupted plaque or throm-
bus debris is amenable to reduced mechanical trauma at
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1221the time of stent expansion. Therefore, designing a
stenting strategy such as the one tested by the investigators
of APPOSITION II seems worthwhile, also in view of the
poor short- and long-term prognosis that is associated with
failure to restore perfusion at the level of the myocardial
tissue.
With this background in mind, the strengths and limi-
tations of the current study become obvious. Van Geuns et
al. (4) have successfully performed a small step toward their
ultimate goal—to contribute to further improving clinical
outcomes after primary PCI for ST-segment elevation
myocardial infarction, a proven lifesaving indication of
percutaneous intervention. This initial step is taking advan-
tage of OCT imaging as an intermediate endpoint allowing
the testing of a simple hypothesis, but one that is mecha-
nistically relevant to the pathophysiology of reperfusion and
reperfusion damage. Rates of strut malapposition after
balloon expansion of metallic stents were high, as expected
from earlier reports, and much lower with STENTYS
(STENTYS, Paris, France). Additional observations, in-
cluding repeat OCT imaging at 3 days showed continued
expansion of the luminal dimensions and further reduction
of strut malapposition with the self-expanding, as opposed
to the balloon-expandable, device.
The observed changes in diameters and areas over time
following implantation were well known from the early days
(2). The question that has remained unanswered is whether
spontaneous expansion is preferable to additional in-stent
post-dilation using balloons. In the present study, the
procedural technique did involve immediate post-stent ex-
pansion via balloon inflation in 63% of cases randomized to
receiving the self-expanding device, as opposed to 24% with
initial balloon expansion. The strategy was dependent on
site or operator preference, and the investigators do not
provide analysis of the pro and cons of either technique.
Even pre-dilation was applied more often in the group
randomized to self-expanding stent implantation: 60.5%
versus 40.5% of cases. It is not mentioned whether limited
dilation was applied merely to allow easy passage of the
delivery catheter or full dilation of the stenosis was per-
formed to facilitate self-expansion of the device. Concep-
tually, it may seem that balloon expansion, either pre- or
post-stent placement, may jeopardize some of the benefits
related to softer self-expansion, but this remains speculative.
It is currently not known whether there are any risks
associated with a conservative strategy, allowing for spon-
taneous stent expansion over the first few days after delivery.
In this context, a more detailed quantitative analysis of stent
underexpansion, as well as a description of “out of round”
stent configurations in both study arms, would have been of
value. Although this can be seen as a limitation of the
present study, one has to admit that the clinical correlates of
these measurements, as well as the implications of OCT-
determined malapposition rates, remain elusive.Study and device limitations. Obviously, the study is not
powered to address differences in clinical metrics. Yet in
keeping with the ultimate goal, the reader may require some
additional information regarding the procedural outcomes.
One may appropriately wonder about the presence of
residual thrombus or tissue prolapse at the level of the
coronary stent. Likewise, it would be of interest to learn
about any differences between randomization groups in
TIMI (Thrombolysis In Myocardial Infarction) flow grade
or myocardial blush grade at the end of the procedure. Such
observations will be much needed to design and size future
outcome-based trials.
However, the main limitation of the current effort per-
tains to the device itself. Restenosis rates of bare-metal
self-expanding stents are high, at best. The mean in-stent
late loss with STENTYS was indeed high at 0.7 mm,
even though the z-shape of the current design differs
entirely from the initial Wallstent design. Fortunately, it
was proven possible to reduce restenosis rates of similar
stents by combining drug elution from bioerodable poly-
mers with self-expanding properties (7) and STENTYS
drug-eluting devices are under clinical evaluation. Fol-
lowing the demonstration that drug elution does not
compromise vascular healing and preserves the opportu-
nity for adequate late apposition, this technology will be
ready for large-scale evaluation in prospective random-
ized trials to test its potential for incrementally improving
the outcome of patients with ST-segment elevation myo-
cardial infarction by reducing reperfusion injury, stent
thrombosis, and restenosis, beyond what is already achiev-
able with contemporary balloon-expandable drug-eluting
stent.
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